A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
2hon MSN
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product ...
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Sleep problems in Parkinson disease are highly prevalent, with over 80% of patients reporting sleep disturbances and insomnia.
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...
The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...
22h
News Medical on MSNFDA-approved technology offers personalized treatment for Parkinson’s symptomsStarting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
A new documentary about Ozzy Osbourne is currently in production at Paramount+. "No Escape From Now" will look behind the ...
20hon MSN
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results